Generic placeholder image

Applied Clinical Research, Clinical Trials and Regulatory Affairs (Discontinued)


ISSN (Print): 2213-476X
ISSN (Online): 2213-4778

Review Article

Glycemic Goal for Older Adults with Diabetes and Concentrated Basal Insulin Options

Author(s): Julienne K. Kirk and Amanda L. Teachey

Volume 3 , Issue 2 , 2016

Page: [82 - 85] Pages: 4

DOI: 10.2174/2213476X03666160524165212

Price: $65


Background: Older patients with diabetes require a provider to consider health status and the ability to self-manage with concomitant morbidities. Careful insight into pharmacotherapy regimens that offer the best profile with appropriate efficacy is critical. Diabetes is a common disorder that is often undertreated in the elderly because of the concern for hypoglycemia. A review of the literature and if newer basal insulin formulations cause less hypoglycemia was assessed.

Methods: We reviewed published society guidelines for older patients with diabetes targeting specific A1C treatment goals. The pharmacokinetic and pharmacodynamic profiles of two new basal insulin therapies and their use in older populations were also evaluated. The overall experience with hypoglycemia and the action profile of newer basal insulins, including insulin degludec and concentrated insulin glargine, are described.

Results: Goals for A1C in older adults should be individualized based on patient characteristics and factors including chronic illnesses, activities of daily living, cognitive impairment and life expectancy. In older patients, intensive insulin dosing may be challenging due to a higher risk of hypoglycemia. Newer basal insulin therapies provide a safe option for daily dosing of insulin and less hypoglycemia compared to traditional insulin choices.

Conclusion: Diabetes is a common disorder among the elderly and insulin is a viable therapy that has to be individualized and adequately monitored to prevent untoward risks of hypoglycemia. Newer basal insulins, if affordable for the patient, offer another choice for therapy.

Keywords: Older patients, A1C goal, diabetes, and basal concentrated Insulin.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy